By Professor Cynthia Shannon Weickert

Book Chapters

Weickert CS; Rothmond DA; Purves-Tyson TD, 2018, 'Considerations for optimal use of postmortem human brains for molecular psychiatry: lessons from schizophrenia', in Handbook of Clinical Neurology, pp. 221 - 235, http://dx.doi.org/10.1016/B978-0-444-63639-3.00016-5

Catts S; Shannon Weickert C, 2017, 'Schizophrenia and related psychotic disorders', in Bloch S; Green SA; Janca A; Mitchell PB; Robertson M (ed.), Foundations of Clinical Psychiatry Fourth Edition, Melbourne University Press, Calrton, Victoria, pp. 316 - 341

Journal articles

Chandra JJ; Zhu Y; Petty A; Kostoglou Y; Haynes WX; Webster MJ; Weickert CS, 2025, 'Transcriptional evidence of reduced BDNF trophic capacity in the post-mortem human midbrain of schizophrenia cases with high inflammation', Translational Psychiatry, 15, http://dx.doi.org/10.1038/s41398-025-03359-7

Koromina M; Ravi A; Panagiotaropoulou G; Schilder BM; Humphrey J; Braun A; Bidgeli T; Chatzinakos C; Coombes BJ; Kim J; Liu X; Terao C; O’Connell KS; Adams MJ; Adolfsson R; Alda M; Alfredsson L; Andlauer TFM; Andreassen OA; Antoniou A; Baune BT; Bengesser S; Biernacka J; Boehnke M; Bosch R; Cairns MJ; Carr VJ; Casas M; Catts S; Cichon S; Corvin A; Craddock N; Dafnas K; Dalkner N; Dannlowski U; Degenhardt F; Di Florio A; Dikeos D; Fellendorf FT; Ferentinos P; Forstner AJ; Forty L; Frye M; Fullerton JM; Gawlik M; Gizer IR; Gordon-Smith K; Green MJ; Grigoroiu-Serbanescu M; Guzman-Parra J; Hahn T; Henskens F; Hillert J; Jablensky AV; Jones L; Jones I; Jonsson L; Kelsoe JR; Kircher T; Kirov G; Kittel-Schneider S; Kogevinas M; Landén M; Leboyer M; Lenger M; Lissowska J; Lochner C; Loughland C; MacIntyre DJ; Martin NG; Maratou E; Mathews CA; Mayoral F; McElroy SL; McGregor NW; McIntosh A; McQuillin A; Michie P; Mitchell PB; Moutsatsou P; Mowry B; Müller-Myhsok B; Myers RM; Nenadić I; Nievergelt CM; Nöthen MM; Nurnberger J; ’Donovan MO; ’Donovan CO; Ophoff RA; Owen MJ; Pantelis C; Pato C; Pato MT; Patrinos GP; Pawlak JM; Perlis RH; Porichi E; Posthuma D; Ramos-Quiroga JA, 2025, 'Fine-mapping genomic loci refines bipolar disorder risk genes', Nature Neuroscience, 28, pp. 1393 - 1403, http://dx.doi.org/10.1038/s41593-025-01998-z

Zhu Y; Webster MJ; Mendez Victoriano G; Middleton FA; Massa PT; Weickert CS, 2025, 'Molecular Evidence for Altered Angiogenesis in Neuroinflammation-Associated Schizophrenia and Bipolar Disorder Implicate an Abnormal Midbrain Blood-Brain Barrier', Schizophrenia Bulletin, 51, pp. 1146 - 1161, http://dx.doi.org/10.1093/schbul/sbae184

Alsema AM; Puvogel S; Kracht L; Webster MJ; Weickert CS; Eggen BJL; Sommer IEC, 2025, 'Schizophrenia-associated changes in neuronal subpopulations in the human midbrain', Brain, 148, pp. 1374 - 1388, http://dx.doi.org/10.1093/brain/awae321

O’Connell KS; Koromina M; van der Veen T; Boltz T; David FS; Yang JMK; Lin KH; Wang X; Coleman JRI; Mitchell BL; McGrouther CC; Rangan AV; Lind PA; Koch E; Harder A; Parker N; Bendl J; Adorjan K; Agerbo E; Albani D; Alemany S; Alliey-Rodriguez N; Als TD; Andlauer TFM; Antoniou A; Ask H; Bass N; Bauer M; Beins EC; Bigdeli TB; Pedersen CB; Boks MP; Børte S; Bosch R; Brum M; Brumpton BM; Brunkhorst-Kanaan N; Budde M; Bybjerg-Grauholm J; Byerley W; Cabana-Domínguez J; Cairns MJ; Carpiniello B; Casas M; Cervantes P; Chatzinakos C; Chen HC; Clarence T; Clarke TK; Claus I; Coombes B; Corfield EC; Cruceanu C; Cuellar-Barboza A; Czerski PM; Dafnas K; Dale AM; Dalkner N; Degenhardt F; DePaulo JR; Djurovic S; Drange OK; Escott-Price V; Fanous AH; Fellendorf FT; Ferrier IN; Forty L; Frank J; Frei O; Freimer NB; Fullard JF; Garnham J; Gizer IR; Gordon SD; Gordon-Smith K; Greenwood TA; Grove J; Guzman-Parra J; Ha TH; Hahn T; Haraldsson M; Hautzinger M; Havdahl A; Heilbronner U; Hellgren D; Herms S; Hickie IB; Hoffmann P; Holmans PA; Huang MC; Ikeda M; Jamain S; Johnson JS; Jonsson L; Kalman JL; Kamatani Y; Kennedy JL; Kim E; Kim J; Kittel-Schneider S; Toma C; Fullerton J; Carr V; Green M; Schofield P; Shannon Weickert C; Mitchell P, 2025, 'Genomics yields biological and phenotypic insights into bipolar disorder', Nature, 639, pp. 968 - 975, http://dx.doi.org/10.1038/s41586-024-08468-9

Victoriano GM; Zhu Y; Middleton F; Webster MJ; Weickert CS, 2025, 'CELL DEATH TRANSCRIPTS OF THE TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY ARE INCREASED IN THE MIDBRAINS OF SCHIZOPHRENIA AND BIPOLAR DISORDER WITH HIGH INFLAMMATION AND ARE NEGATIVELY ASSOCIATED WITH DOPAMINE TRANSCRIPTS', INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 28, pp. i234 - i235, http://dx.doi.org/10.1093/ijnp/pyae059.411

McCaffrey D; Weickert CS; Walker AK, 2025, 'Blood IL-1α and IL-6 predict specific breast cancer-induced increases in hippocampal pro-inflammatory cytokines in mice', Cytokine, 186, http://dx.doi.org/10.1016/j.cyto.2024.156826

Sager REH; North HF; Weissleder C; Clearwater MS; Walker AK; Fullerton JM; Webster MJ; Shannon Weickert C, 2025, 'Divergent changes in complement pathway gene expression in schizophrenia and bipolar disorder: Links to inflammation and neurogenesis in the subependymal zone', Schizophrenia Research, 275, pp. 25 - 34, http://dx.doi.org/10.1016/j.schres.2024.11.005

Walpole S; Kostoglou Y; Haynes W; Shannon Weickert C; Newell K, 2025, '474. Midbrain Alterations in Metabotropic Glutamate Receptor Transcripts in Schizophrenia and Bipolar Disorder', Biological Psychiatry, 97, pp. S292 - S293, http://dx.doi.org/10.1016/j.biopsych.2025.02.712

Omlor W; Rabe F; Fuchs S; Surbeck W; Cecere G; Huang G-Y; Homan S; Kallen N; Georgiadis F; Spiller T; Seifritz E; Weickert T; Bruggemann J; Weickert C; Potkin S; Hashimoto R; Sim K; Rootes-Murdy K; Quide Y; Houenou J; Banaj N; Piras F; Piras F; Spalletta G; Salvador R; Karuk A; Vecchio D; Pomarol-Clotet E; Rodrigue A; Pearlson G; Glahn D; Tomecek D; Spaniel F; Skoch A; Kirschner M; Kaiser S; Kochunov P; Fan F-M; Andreassen OA; Westlye LT; Berthet P; Calhoun VD; Howells F; Scheffler F; Stein D; Iasevoli F; Cairns MJ; Carr VJ; Uhlmann A; V. Catts S; Biase MAD; Jablensky A; Green MJ; Henskens FA; Klauser P; Loughland C; Michie PT; Mowry B; Pantelis C; Rasser PE; Schall U; Scott R; Zalesky A; de Bartolomeis A; Barone A; Ciccarelli M; Brunetti A; Cocozza S; Pontillo G; Tranfa M; Di Giorgio A; Thomopoulos SI; Jahanshad N; Thompson PM; van Erp T; Turner J; Homan P, 2025, 'Estimating Multimodal Structural Brain Variability in Schizophrenia Spectrum Disorders: A Worldwide ENIGMA', AMERICAN JOURNAL OF PSYCHIATRY, 182, pp. 373 - 388, http://dx.doi.org/10.1176/appi.ajp.20230806

Debs S; Conn I; Navaneethan B; Penklis A; Weickert CS; Purves-Tyson TD, 2025, 'MATERNAL IMMUNE ACTIVATION AND ESTROGEN RECEPTOR MODULATION INDUCE SEX-SPECIFIC DOPAMINE-RELATED BEHAVIOURAL AND MOLECULAR ALTERATIONS IN ADULT RAT OFFSPRING', INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 28, pp. ii51 - ii52, http://dx.doi.org/10.1093/ijnp/pyaf052.102

Brand BA; de Boer JN; Willemse EJM; Weickert CS; Sommer IE; Weickert TW, 2024, 'Antipsychotic-induced prolactin elevation in premenopausal women with schizophrenia: associations with estrogen, disease severity and cognition', Archives of Women S Mental Health, 27, pp. 931 - 941, http://dx.doi.org/10.1007/s00737-024-01491-9

North HF; Weissleder C; Bitar M; Barry G; Fullerton JM; Webster MJ; Weickert CS, 2024, 'RNA-sequencing suggests extracellular matrix and vasculature dysregulation could impair neurogenesis in schizophrenia cases with elevated inflammation', Schizophrenia, 10, http://dx.doi.org/10.1038/s41537-024-00466-0

Mendez-Victoriano G; Zhu Y; Middleton F; Massa PT; Ajulu K; Webster MJ; Weickert CS; Mendez Victoriano G, 2024, 'Increased Parenchymal Macrophages are associated with decreased Tyrosine Hydroxylase mRNA levels in the Substantia Nigra of people with Schizophrenia and Bipolar Disorder', Psychiatry Research, 340, pp. 116141, http://dx.doi.org/10.1016/j.psychres.2024.116141

Debs SR; Rothmond DA; Zhu Y; Weickert CS; Purves-Tyson TD, 2024, 'Molecular evidence of altered stress responsivity related to neuroinflammation in the schizophrenia midbrain', Journal of Psychiatric Research, 177, pp. 118 - 128, http://dx.doi.org/10.1016/j.jpsychires.2024.07.004

Hamers IMH; Brand BA; Begemann MJH; Weickert CS; Weickert TW; Sommer IEC, 2024, 'The association of prolactin and gonadal hormones with cognition and symptoms in men with schizophrenia spectrum disorder: Divergent effects of testosterone and estrogen', Schizophrenia Research, 270, pp. 273 - 280, http://dx.doi.org/10.1016/j.schres.2024.06.022

Debs SR; Conn I; Navaneethan B; Penklis AG; Meyer U; Killcross S; Weickert CS; Purves-Tyson TD, 2024, 'Maternal immune activation and estrogen receptor modulation induce sex-specific dopamine-related behavioural and molecular alterations in adult rat offspring', Brain Behavior and Immunity, 118, pp. 236 - 251, http://dx.doi.org/10.1016/j.bbi.2024.02.034

Puvogel S; Alsema A; North HF; Webster MJ; Weickert CS; Eggen BJL, 2024, 'Single-Nucleus RNA-Seq Characterizes the Cell Types Along the Neuronal Lineage in the Adult Human Subependymal Zone and Reveals Reduced Oligodendrocyte Progenitor Abundance with Age', Eneuro, 11, pp. 1 - 19, http://dx.doi.org/10.1523/ENEURO.0246-23.2024

Weickert TW; Ji E; Galletly C; Boerrigter D; Morishima Y; Bruggemann J; Balzan R; O'Donnell M; Liu D; Lenroot R; Weickert CS; Kindler J, 2024, 'Toll-Like Receptor mRNA Levels in Schizophrenia: Association With Complement Factors and Cingulate Gyrus Cortical Thinning', Schizophrenia Bulletin, 50, pp. 403 - 417, http://dx.doi.org/10.1093/schbul/sbad171

Brown SJ; Christofides K; Weissleder C; Huang XF; Shannon Weickert C; Lim CK; Newell KA, 2024, 'Sex- and suicide-specific alterations in the kynurenine pathway in the anterior cingulate cortex in major depression', Neuropsychopharmacology, 49, pp. 584 - 592, http://dx.doi.org/10.1038/s41386-023-01736-8

Weickert TW; Weickert CS, 2024, 'A path to novel, effective treatments for schizophrenia', Neuropsychopharmacology, 49, pp. 321 - 322, http://dx.doi.org/10.1038/s41386-023-01705-1

Weickert TW; Jacomb I; Lenroot R; Lappin J; Weinberg D; Brooks WS; Brown D; Pellen D; Kindler J; Mohan A; Wakefield D; Lloyd AR; Stanton C; O'Donnell M; Liu D; Galletly C; Shannon Weickert C, 2024, 'Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial', Brain Behavior and Immunity, 115, pp. 191 - 200, http://dx.doi.org/10.1016/j.bbi.2023.10.012

McWhinney SR; Brosch K; Calhoun VD; Crespo-Facorro B; Crossley NA; Dannlowski U; Dickie E; Dietze LMF; Donohoe G; Du Plessis S; Ehrlich S; Emsley R; Furstova P; Glahn DC; Gonzalez- Valderrama A; Grotegerd D; Holleran L; Kircher TTJ; Knytl P; Kolenic M; Lencer R; Nenadić I; Opel N; Pfarr JK; Rodrigue AL; Rootes-Murdy K; Ross AJ; Sim K; Škoch A; Spaniel F; Stein F; Švancer P; Tordesillas-Gutiérrez D; Undurraga J; Vázquez-Bourgon J; Voineskos A; Walton E; Weickert TW; Weickert CS; Thompson PM; van Erp TGM; Turner JA; Hajek T, 2024, 'Correction to: Obesity and brain structure in schizophrenia – ENIGMA study in 3021 individuals (Molecular Psychiatry, (2022), 27, 9, (3731-3737), 10.1038/s41380-022-01616-5)', Molecular Psychiatry, 29, pp. 56, http://dx.doi.org/10.1038/s41380-023-02055-6

Bayes A; Weickert TW; Parker G; Spoelma MJ; North HF; Lam-Po-Tang J; Weickert CS, 2024, 'Peripheral inflammatory markers in melancholic versus non-melancholic depression', Psychoneuroendocrinology, 159, http://dx.doi.org/10.1016/j.psyneuen.2023.106418

Weickert T; Ramanathan S; Lenroot R; Liu D; Ballas S; Balzan R; O'Donnell M; Galletly C; Weickert C, 2024, 'Intellectual decline with illness onset is related to elevated peripheral inflammation in schizophrenia', BRAIN BEHAVIOR AND IMMUNITY, 122, http://dx.doi.org/10.1016/j.bbi.2024.12.103

Zheng H; Webster MJ; Weickert CS; Beasley CL; Paulus MP; Yolken RH; Savitz J, 2023, 'Cytomegalovirus antibodies are associated with mood disorders, suicide, markers of neuroinflammation, and microglia activation in postmortem brain samples', Molecular Psychiatry, 28, pp. 5282 - 5292, http://dx.doi.org/10.1038/s41380-023-02162-4

Mohamed Saini S; Bousman CA; Mancuso SG; Cropley V; Van Rheenen TE; Lenroot RK; Bruggemann J; Weickert CS; Weickert TW; Sundram S; Everall IP; Pantelis C, 2023, 'Genetic variation in glutamatergic genes moderates the effects of childhood adversity on brain volume and IQ in treatment-resistant schizophrenia', Schizophrenia, 9, http://dx.doi.org/10.1038/s41537-023-00381-w

Managò F; Scheggia D; Pontillo M; Mereu M; Mastrogiacomo R; Udayan G; Valentini P; Tata MC; Weinberger DR; Weickert CS; Pompa PP; De Luca MA; Vicari S; Papaleo F, 2023, 'Dopaminergic signalling and behavioural alterations by Comt–Dtnbp1 genetic interaction and their clinical relevance', British Journal of Pharmacology, 180, pp. 2514 - 2531, http://dx.doi.org/10.1111/bph.16147

Alexandros Lalousis P; Schmaal L; Wood SJ; L.E.P Reniers R; Cropley VL; Watson A; Pantelis C; Suckling J; Barnes NM; Pariante C; Jones PB; Joyce E; Barnes TRE; Lawrie SM; Husain N; Dazzan P; Deakin B; Shannon Weickert C; Upthegrove R, 2023, 'Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneity', Brain Behavior and Immunity, 113, pp. 166 - 175, http://dx.doi.org/10.1016/j.bbi.2023.06.023

Sager REH; Walker AK; Middleton FA; Robinson K; Webster MJ; Gentile K; Wong ML; Shannon Weickert C, 2023, 'Changes in cytokine and cytokine receptor levels during postnatal development of the human dorsolateral prefrontal cortex', Brain Behavior and Immunity, 111, pp. 186 - 201, http://dx.doi.org/10.1016/j.bbi.2023.03.015

Zhu Y; Webster MJ; Walker AK; Massa P; Middleton FA; Weickert CS, 2023, 'Increased prefrontal cortical cells positive for macrophage/microglial marker CD163 along blood vessels characterizes a neuropathology of neuroinflammatory schizophrenia', Brain Behavior and Immunity, 111, pp. 46 - 60, http://dx.doi.org/10.1016/j.bbi.2023.03.018

Nisha Aji K; Hafizi S; Da Silva T; Kiang M; Rusjan PM; Weickert CS; Mizrahi R, 2023, 'Interaction between Peripheral and Central immune markers in Clinical High Risk for Psychosis', Brain Behavior and Immunity Health, 30, http://dx.doi.org/10.1016/j.bbih.2023.100636

Lotan A; Luza S; Opazo CM; Ayton S; Lane DJR; Mancuso S; Pereira A; Sundram S; Weickert CS; Bousman C; Pantelis C; Everall IP; Bush AI, 2023, 'Perturbed iron biology in the prefrontal cortex of people with schizophrenia', Molecular Psychiatry, 28, pp. 2058 - 2070, http://dx.doi.org/10.1038/s41380-023-01979-3

Schijven D; Postema MC; Fukunaga M; Matsumoto J; Miura K; de Zwarte SMC; van Haren NEM; Cahn W; Hulshoff Pol HE; Kahn RS; Ayesa-Arriola R; Ortiz-García de la Foz V; Tordesillas-Gutierrez D; Vázquez-Bourgon J; Crespo-Facorro B; Alnæs D; Dahl A; Westlye LT; Agartz I; Andreassen OA; Jönsson EG; Kochunov P; Bruggemann JM; Catts SV; Michie PT; Mowry BJ; Quidé Y; Rasser PE; Schall U; Scott RJ; Carr VJ; Green MJ; Henskens FA; Loughland CM; Pantelis C; Weickert CS; Weickert TW; de Haan L; Brosch K; Pfarr JK; Ringwald KG; Stein F; Jansen A; Kircher TTJ; Nenadić I; Krämer B; Gruber O; Satterthwaite TD; Bustillo J; Mathalon DH; Preda A; Calhoun VD; Ford JM; Potkin SG; Chen J; Tan Y; Wang Z; Xiang H; Fan F; Bernardoni F; Ehrlich S; Fuentes-Claramonte P; Garcia-Leon MA; Guerrero-Pedraza A; Salvador R; Sarró S; Pomarol-Clotet E; Ciullo V; Piras F; Vecchio D; Banaj N; Spalletta G; Michielse S; van Amelsvoort T; Dickie EW; Voineskos AN; Sim K; Ciufolini S; Dazzan P; Murray RM; Kim WS; Chung YC; Andreou C; Schmidt A; Borgwardt S; McIntosh AM; Whalley HC; Lawrie SM; du Plessis S; Luckhoff HK; Scheffler F; Emsley R; Grotegerd D; Lencer R; Dannlowski U; Edmond JT; Rootes-Murdy K; Stephen JM; Mayer AR; Antonucci LA; Quide Y, 2023, 'Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium', Proceedings of the National Academy of Sciences of the United States of America, 120, pp. 1 - 12, http://dx.doi.org/10.1073/pnas.2213880120

Brown SJ; Brown AM; Purves-Tyson TD; Huang XF; Shannon Weickert C; Newell KA, 2023, 'GRIN2B gene expression is increased in the anterior cingulate cortex in major depression', Journal of Psychiatric Research, 160, pp. 204 - 209, http://dx.doi.org/10.1016/j.jpsychires.2023.02.017

Liu D; Meyer D; Fennessy B; Feng C; Cheng E; Johnson JS; Park YJ; Rieder MK; Ascolillo S; de Pins A; Dobbyn A; Lebovitch D; Moya E; Nguyen TH; Wilkins L; Hassan A; Aghanwa HS; Ansari M; Asif A; Aslam R; Ayuso JL; Bigdeli T; Bignotti S; Bobes J; Bradley B; Buckley P; Cairns MJ; Catts SV; Chaudhry AR; Cohen D; Collins BL; Consoli A; Costas J; Crespo-Facorro B; Daskalakis NP; Davidson M; Davis KL; Dickerson F; Dogar IA; Drapeau E; Fañanás L; Fanous A; Fatima W; Fatjo M; Filippich C; Friedman J; Fullard JF; Georgakopoulos P; Giannitelli M; Giegling I; Green MJ; Guillin O; Gutierrez B; Handoko HY; Hansen SK; Haroon M; Haroutunian V; Henskens FA; Hussain F; Jablensky AV; Junejo J; Kelly BJ; Khan SUDA; Khan MNS; Khan A; Khawaja HR; Khizar B; Kleopoulos SP; Knowles J; Konte B; Kusumawardhani AAAA; Leghari N; Liu X; Lori A; Loughland CM; Mahmood K; Mahmood S; Malaspina D; Malik D; McNaughton A; Michie PT; Michopolous V; Molina E; Molto MD; Munir A; Muntané G; Naeem F; Nancarrow DJ; Nasar A; Nasr T; Ohaeri JU; Ott J; Pantelis C; Periyasamy S; Pinto AG; Powers A; Ramos B; Rana NH; Rapaport M; Reichenberg A, 2023, 'Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations', Nature Genetics, 55, pp. 369 - 376, http://dx.doi.org/10.1038/s41588-023-01305-1

Chen Y; Dai J; Tang L; Mikhailova T; Liang Q; Li M; Zhou J; Kopp RF; Weickert C; Chen C; Liu C, 2023, 'Neuroimmune transcriptome changes in patient brains of psychiatric and neurological disorders', Molecular Psychiatry, 28, pp. 710 - 721, http://dx.doi.org/10.1038/s41380-022-01854-7

Docherty AR; Mullins N; Ashley-Koch AE; Qin X; Coleman JRI; Shabalin A; Kang JE; Murnyak B; Wendt F; Adams M; Campos AI; DiBlasi E; Fullerton JM; Kranzler HR; Bakian AV; Monson ET; Rentería ME; Walss-Bass C; Andreassen OA; Behera C; Bulik CM; Edenberg HJ; Kessler RC; John Mann J; Nurnberger JI; Pistis G; Streit F; Ursano RJ; Polimanti R; Dennis M; Garrett M; Hair L; Harvey P; Hauser ER; Hauser MA; Huffman J; Jacobson D; Madduri R; McMahon B; Oslin DW; Trafton J; Awasthi S; Berrettini WH; Bohus M; Chang X; Chen HC; Chen WJ; Christensen EDMD; Crow S; Duriez P; Edwards AC; Fernández-Aranda F; Galfalvy H; Gandal M; Gorwood P; Guo Y; Hafferty JD; Hakonarson H; Halmi KA; Hishimoto A; Jain S; Jamain S; Jiménez-Murcia S; Johnson C; Kaplan AS; Kaye WH; Keel PK; Kennedy JL; Kim M; Klump KL; Levey DF; Li D; Liao SC; Lieb K; Lilenfeld L; Marshall CR; Mitchell JE; Okazaki S; Otsuka I; Pinto D; Powers A; Ramoz N; Ripke S; Roepke S; Rozanov V; Scherer SW; Schmahl C; Sokolowski M; Starnawska A; Strober M; Su MH; Thornton LM; Treasure J; Ware EB; Watson HJ; Witt SH; Blake Woodside D; Yilmaz Z; Zillich L; Adolfsson R, 2023, 'GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors', American Journal of Psychiatry, 180, pp. 723 - 738, http://dx.doi.org/10.1176/appi.ajp.21121266

Lalousis DPA; Schmaal L; Wood S; Reniers R; Cropley V; Pantelis C; Weickert C; Upthegrove R, 2023, 'Using machine learning to improve pathways for precision medicine in psychiatry', Neuroscience Applied, 2, pp. 103374 - 103374, http://dx.doi.org/10.1016/j.nsa.2023.103374

McCaffrey D; Lawther AJ; Weickert CS; Walker AK, 2022, 'Cancer activates microglia to the same extent as chronic stress throughout stress neurocircuitry in a mouse model of breast cancer', Psychoneuroendocrinology, 146, http://dx.doi.org/10.1016/j.psyneuen.2022.105938

Bitar M; Weissleder C; North HF; Clearwater MS; Zalucki O; Halliday GM; Webster MJ; Piper M; Weickert CS; Barry G, 2022, 'Identifying gene expression profiles associated with neurogenesis and inflammation in the human subependymal zone from development through aging', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-021-03976-4

Petty A; Glass LJ; Rothmond DA; Purves-Tyson T; Sweeney A; Kondo Y; Kubo S; Matsumoto M; Weickert CS, 2022, 'Increased levels of a pro-inflammatory IgG receptor in the midbrain of people with schizophrenia', Journal of Neuroinflammation, 19, http://dx.doi.org/10.1186/s12974-022-02541-8

Murphy CE; Walker AK; O’Donnell M; Galletly C; Lloyd AR; Liu D; Weickert CS; Weickert TW; ODonnell M, 2022, 'Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases', Translational Psychiatry, 12, pp. 21, http://dx.doi.org/10.1038/s41398-021-01764-2

Visini G; Brown S; Weston-Green K; Shannon Weickert C; Chesworth R; Karl T, 2022, 'The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia', Frontiers in Cellular Neuroscience, 16, http://dx.doi.org/10.3389/fncel.2022.1010478

Puvogel S; Alsema A; Kracht L; Webster MJ; Weickert CS; Sommer IEC; Eggen BJL, 2022, 'Single-nucleus RNA sequencing of midbrain blood-brain barrier cells in schizophrenia reveals subtle transcriptional changes with overall preservation of cellular proportions and phenotypes', Molecular Psychiatry, 27, pp. 4731 - 4740, http://dx.doi.org/10.1038/s41380-022-01796-0

O'Donnell M; Teasdale S; Chua X-Y; Hardman J; Wu N; Curtis J; Samaras K; Bolton P; Morris M; Shannon-Weickert C; Purves-Tyson T; El-Assaad F; Jiang X; Hold G; El-Omar E; Wu N, 2022, 'The role of the microbiome in the metabolic health of people with schizophrenia and related psychoses: cross-sectional and pre-post lifestyle intervention analyses', Pathogens, 11, pp. 1279, http://dx.doi.org/10.3390/pathogens11111279

Ringin E; Cropley V; Zalesky A; Bruggemann J; Sundram S; Weickert CS; Weickert TW; Bousman CA; Pantelis C; Van Rheenen TE, 2022, 'The impact of smoking status on cognition and brain morphology in schizophrenia spectrum disorders', Psychological Medicine, 52, pp. 3097 - 3115, http://dx.doi.org/10.1017/S0033291720005152

Mastrogiacomo R; Trigilio G; Devroye C; Dautan D; Ferretti V; Losi G; Caffino L; Orso G; Marotta R; Maltese F; Vitali E; Piras G; Forgiarini A; Pacinelli G; Lia A; Rothmond DA; Waddington JL; Drago F; Fumagalli F; Luca MAD; Leggio GM; Carmignoto G; Weickert CS; Managò F; Papaleo F, 2022, 'Dysbindin-1A modulation of astrocytic dopamine and basal ganglia dependent behaviors relevant to schizophrenia', Molecular Psychiatry, 27, pp. 4201 - 4217, http://dx.doi.org/10.1038/s41380-022-01683-8

Back to profile page